首页> 外国专利> BENZIMIDAZOLE OR BENZOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASE, DIABETES, AND COMPLICATIONS THEREOF

BENZIMIDAZOLE OR BENZOXAZOLE DERIVATIVES FOR PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASE, DIABETES, AND COMPLICATIONS THEREOF

机译:苯并咪唑或苯并恶唑衍生物用于预防和治疗中枢神经系统疾病,糖尿病及其并发症

摘要

The present invention provides a pharmaceutical composition for preventing and treating central nervous system (CNS) diseases, diabetes and complications thereof, the pharmaceutical composition comprising, as an active ingredient, a benzimidazole or benzoxazole derivative having the structure of chemical formula 1 or a pharmaceutically acceptable salt thereof. The benzimidazole or benzoxazole derivative used as an active ingredient in the pharmaceutical composition of the present invention can, via an Nrf2 activation mechanism caused by the Keap1-Nrf2-ARE pathway and via an activation pathway of glutamate transporters such as GLT-1/EAAT and GLAST, inhibit oxidative damage in the central nervous system and the pancreas while inducing production of an antioxidant such as glutathione, thereby maximizing the effect of treating central nervous system diseases, diabetes and complications thereof.
机译:本发明提供了用于预防和治疗中枢神经系统(CNS)疾病,糖尿病及其并发症的药物组合物,所述药物组合物作为活性成分,苯并咪唑或苯并恶唑衍生物具有具有化学式1的结构或药学上可接受的 盐。 在本发明的药物组合物中使用的苯并咪唑或苯并恶唑衍生物可以通过由Keap1-NRF2-是途径引起的NRF2活化机制,并通过谷氨酸转运蛋白的活化途径,如GLT-1 / EAAT和 Plast,抑制中枢神经系统和胰腺的氧化损伤,同时诱导抑制抑制剂如谷胱甘肽,从而最大限度地提高治疗中枢神经系统疾病,糖尿病及其并发症的作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号